Amgen News
Most Popular Amgen Story
The race is on for muscle-enhancing therapies
The key to extraordinary muscle growth is inhibiting the gene that expresses myostatin, which blocks the growth of skeletal muscle. And now there's a race among a group of drug developers to bring a... Read more...
Latest Headlines
- August 26, 2008
- October 23, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
